Part, Chapter, Paragraph
1 I, 2. 2 | Community. It reveals that Europe is a very stable tourist
2 I, 2. 2 | towards global tourism – Europe consolidated its position
3 I, 2. 2 | they continued growing in Europe. Since 2004 global international
4 I, 2. 2 | contributed to improving Europe’s position as a tourist
5 I, 2. 2 | the growing cooperation of Europe with low-income countries
6 I, 2. 2 | entrance of these diseases in Europe. Environmental, ecological
7 I, 2. 2 | effect of global warming on Europe in the years ahead could
8 I, 2. 2 | in those areas, including Europe. Moreover, with their different
9 I, 2. 3 | During the past 20 years, Europe experienced very important
10 I, 2. 3 | relation to skill level, Europe attracts less high skilled
11 I, 2. 3 | consequences of this practice in Europe and, moreover, the human
12 I, 2. 4 | trends and inequalities~ ~Europe continues to become wealthier.
13 I, 2. 4 | groups and also between Europe and neighbouring countries.~ ~
14 I, 2. 4 | therefore fundamental to Europe’s sustainable development.
15 I, 2. 4 | economy in these countries.~ ~Europe has become wealthier overall
16 I, 2. 4 | groups and also between Europe and neighbouring countries.
17 I, 2. 4 | High risk populations in Europe, indicated by low level
18 I, 2. 4 | mortality were in Eastern Europe at least as big, and perhaps
19 I, 2. 4 | even bigger than in Western Europe. For example, a study looking
20 I, 2. 4 | many countries in Eastern Europe, sometimes for the better (
21 I, 2. 4 | in income inequality in Europe in the next 20 years. Larger
22 I, 2. 5 | in income inequality in Europe in the next 20 years. Larger
23 I, 2. 5 | Commission’s Employment in Europe report, published in early
24 I, 2. 5 | million unfilled jobs in Europe. Growing labour needs are
25 I, 2. 5 | adapt.~ ~The situation in Europe in terms of migration is
26 I, 2. 5 | relation to skill level, Europe attracts less high skilled
27 I, 2. 5 | increasing in all countries in Europe with more weekend work,
28 I, 2. 7 | to be a single city; in Europe, South-East England has
29 I, 2. 8 | air emissions in parts of Europe, the energy supply sector
30 I, 2. 9 | by 1.0 °C for land alone. Europe has warmed more than the
31 I, 2. 9 | temperature increases in Europe between 1.0–5.5 °C by the
32 I, 2. 9 | the north–eastern part of Europe. Climate change alters the
33 I, 2. 9 | Mediterranean and central-eastern Europe and, together with prolonged
34 I, 2. 9 | that winter mortality in Europe has decreased, but this
35 I, 2. 9 | has extended its range in Europe substantially over the past
36 I, 2. 10. 2 | the target tissue.~ ~For Europe, data on the actual use
37 I, 2. 10. 3 | decade. In particular, the Europe 2005 Action Plan targeted
38 I, 2. 10. 3 | of the competitiveness of Europe’s ICT sector within the
39 I, 2. 10. 3 | integrated strategy to boost Europe’s digital economy. With
40 I, 2. 10. 4(8) | medication safety culture in Europe. Building up safe medication
41 I, 2. 10. 4(8) | Medication Practisise. Council of Europe - 2007~
42 I, 2. 10. 4 | Drug counterfeiting~ ~In Europe, around 1% of pharmaceuticals
43 I, 2. 10. 4 | Practices of the Council of Europe strongly recommends the
44 I, 2. 10. 4(21)| medication safety culture in Europe: Building up sa medication
45 I, 2. 11 | EEA-JRC-WHO report “Impacts of Europe's changing climate — 2008
46 I, 2. 11 | satisfaction: evidence from Europe. Available at: ftp ~ ~EUROSTAT (
47 I, 2. 11 | the statistical guide to Europe. Available at: htt ~ ~EUROSTAT (
48 I, 2. 11 | life of women and men in Europe 2008 edition. A statistical
49 I, 3. 1 | Slovenia and Sweden; nowhere in Europe was this number below 2.
50 I, 3. 1 | States. Northern and Western Europe were the first regions where
51 I, 3. 1 | somewhat later. In Eastern Europe this trend has been visible
52 I, 3. 1 | slightly lower in Eastern Europe. Currently the age is around
53 I, 3. 1 | Northern, Western and Southern Europe, while Eastern Europe is
54 I, 3. 1 | Southern Europe, while Eastern Europe is lagging behind with levels
55 I, 3. 1 | a bit earlier in Eastern Europe.~Currently, cohort TFRs
56 I, 3. 1 | in Eastern and Southern Europe with currently ‘lowest low
57 I, 3. 2 | or countries of Eastern Europe. The strict immigration
58 I, 3. 2 | During the past 20 years, Europe experienced very important
59 I, 3. 4 | HWWA) (2004): Migrants in Europe and their Economic Position:~
60 I, 3. 4 | 1993): L’infecondité en Europe, in A. Blum e J. L. Rallu (
61 II, 4. 1 | that the Baltic and Eastern Europe countries are found as their
62 II, 4. 2 | South, Central and Eastern Europe. Therefore, they may be
63 II, 4. 3 | to monitor health across Europe: the Euro-REVES 2 project.
64 II, 4. 3 | to monitor health across Europe: The Euro-REVES 2 project.
65 II, 5. 1. 1 | in Eastern and Southern Europe and the second in Western
66 II, 5. 1. 1 | in Western and Northern Europe. Therefore, awareness of
67 II, 5. 2. 1 | million deaths each year in Europe and more than 2.0 million
68 II, 5. 2. 1 | mid 70s, but in Eastern Europe mortality has remained stable
69 II, 5. 2. 1 | costs. Therefore, across Europe there is a pressing need
70 II, 5. 2. 2 | mortality in Western and Eastern Europe and regional variations [
71 II, 5. 2. 2 | characteristics to those of Northern Europe and mortality rates are
72 II, 5. 2. 2 | included among Northern Europe countries because mortality
73 II, 5. 2. 2 | populations of Northern Europe; such an approach is understood
74 II, 5. 2. 3 | Central Eastern and Eastern Europe countries (Table 5.2.1).
75 II, 5. 2. 3(1) | Baltic Europe countries include: Estonia,
76 II, 5. 2. 3 | 45% in Central Eastern Europe countries3 (from 440 to
77 II, 5. 2. 3 | 100.000), 27% in Eastern Europe countries4 (from 450 to
78 II, 5. 2. 3(3) | Central Eastern Europe countries include: Czech Republic,
79 II, 5. 2. 3 | 100.000), 37% in Central Europe countries5 (from 225 to
80 II, 5. 2. 3(4) | Eastern Europe countries include: Bulgaria,
81 II, 5. 2. 3 | 100.000), 34% in Southern Europe countries6 (from 139 to
82 II, 5. 2. 3(5) | Central Europe countries include: Belgium,
83 II, 5. 2. 3(6) | Southern Europe countries include: Greece,
84 II, 5. 2. 3 | rates fell by 40% in Central Europe countries (from 73 to 44
85 II, 5. 2. 3 | 51% in Central Eastern Europe countries (from 157 to 77
86 II, 5. 2. 3 | 100.000), 23% in Eastern Europe countries (from 169 to 130
87 II, 5. 2. 3 | 100.000), 41% in Northern Europe (from 102 to 61 per 100.
88 II, 5. 2. 3 | 100.000), 36% in Baltic Europe countries (from 231 to 148
89 II, 5. 2. 3 | 000) and 41% in Southern Europe countries (from 40 to 23
90 II, 5. 2. 3 | data vary widely across Europe and all countries have seen
91 II, 5. 2. 3 | Central Eastern and Eastern Europe countries have lower rates
92 II, 5. 2. 3 | Central Eastern and Eastern Europe than in Southern Europe
93 II, 5. 2. 3 | Europe than in Southern Europe countries; for men living
94 II, 5. 2. 3 | Central Eastern and Eastern Europe countries than in Northern
95 II, 5. 2. 3 | in Northern and Southern Europe countries (Tunstall-Pedoe
96 II, 5. 2. 3 | population based registers in Europe adopt different data collection
97 II, 5. 2. 3(7) | Baltic Europe countries include: Latvia,
98 II, 5. 2. 3 | 84 fell by 63% in Central Europe (from 133 to 49 per 100.
99 II, 5. 2. 3 | 100.000), 40% in Southern Europe countries (from 136 to 82
100 II, 5. 2. 3 | 34% in Central Eastern Europe (from 273 to 180 per 100.
101 II, 5. 2. 3 | 100.000) and 6% in Baltic Europe countries (from 298 to 279
102 II, 5. 2. 3 | increased by 10% in Eastern Europe (from 324 to 357 per 100.
103 II, 5. 2. 3 | mortality rates in Central Europe countries were more than
104 II, 5. 2. 3 | times lower than in Eastern Europe countries. Temporal trends
105 II, 5. 2. 3 | in Central and Southern Europe and showed a clear East-West
106 II, 5. 2. 3 | mortality rates in Baltic Europe and Eastern Europe.~ ~Figure
107 II, 5. 2. 3 | Baltic Europe and Eastern Europe.~ ~Figure 5.2.3. Age-standardized (
108 II, 5. 2. 3 | rates fell by 39% in Central Europe (from 89 to 54 per 100.000),
109 II, 5. 2. 3 | 100.000), 46% in Southern Europe countries (from 99 to 54
110 II, 5. 2. 3 | 100.000), 13% in Baltic Europe countries (from 218 to 189
111 II, 5. 2. 3 | and 37% in Central Eastern Europe (from 193 to 121 per 100.
112 II, 5. 2. 3 | increased by 21% in Eastern Europe (from 203 to 246 per 100.
113 II, 5. 2. 3 | mortality rates in Southern Europe were more than four times
114 II, 5. 2. 3 | times lower than in Eastern Europe countries.~ ~Figure 5.2.
115 II, 5. 2. 3 | populations in Northern Europe (Lithuania, Finland, Northern
116 II, 5. 2. 3 | men and women in Eastern Europe. The political, social and
117 II, 5. 2. 4 | Southern, Baltic and Eastern Europe than in Northern countries.
118 II, 5. 2. 4 | generally higher in Northern Europe and Southern Europe than
119 II, 5. 2. 4 | Northern Europe and Southern Europe than in Central Eastern
120 II, 5. 2. 4 | heart attacks in Western Europe and 25% in Central Eastern
121 II, 5. 2. 4 | Central Eastern and Eastern Europe are due to a history of
122 II, 5. 2. 5 | identify best practices in Europe and ensure solidarity among
123 II, 5. 2. 7 | population-based registers in Europe: are morbidity indicators
124 II, 5. 2. 7 | cardiovascular diseases mortality in Europe. Task force of the European
125 II, 5. 2. 7 | morbidity statistics in Europe. Eur Heart J 18: 1231–48.~
126 II, 5. 2. 7 | WHO Regional Office for Europe (2007): The Second WHO European
127 II, 5. 3.Acr | Medical Oncology Status in Europe Survey~NCP~National caner
128 II, 5. 3. 1 | the major cancer killer in Europe; cancers of female breast,
129 II, 5. 3. 2 | national population. However in Europe some Member States do not
130 II, 5. 3. 2 | cancer registries operate in Europe today, playing a key role
131 II, 5. 3. 2 | control monitoring across Europe. Cancer Registries should
132 II, 5. 3. 2 | standardized data comparable across Europe;~· cancer registries are
133 II, 5. 3. 2 | in cancer information in Europe and is a recognised European
134 II, 5. 3. 2 | EUROCARE – Cancer survival in Europe: The EUROCARE project was
135 II, 5. 3. 2 | cancer survival rates across Europe. A further aim is to compare
136 II, 5. 3. 2 | improve cancer research in Europe; analysis and synthesis
137 II, 5. 3. 2 | National Cancer Plans in Europe; evaluation of potential
138 II, 5. 3. 2 | cancer care and practice in Europe. ESMO performed the ‘MOSES’ (
139 II, 5. 3. 2 | Medical Oncology Status in Europe Survey) Project. It collected
140 II, 5. 3. 2 | status of medical oncology in Europe through questionnaires.
141 II, 5. 3. 3 | geographical area (Eastern Europe: Bulgaria, Czech Republic,
142 II, 5. 3. 3 | Romania, Slovakia; Northern Europe: Denmark, Estonia, Finland,
143 II, 5. 3. 3 | United Kingdom; Southern Europe: Greece, Italy, Malta, Portugal,
144 II, 5. 3. 3 | Slovenia, Spain; Western Europe: Austria, Belgium, France,
145 II, 5. 3. 4 | in Eastern and Southern Europe and the second in Western
146 II, 5. 3. 4 | in Western and Northern Europe. Therefore, awareness of
147 II, 5. 3. 5 | for all cancers all around Europe (Ferlay et al, 2007). Maximum
148 II, 5. 3. 5 | in 2006 were in Western Europe for men (482 new cases per
149 II, 5. 3. 5 | 5.3.2a) and in Northern Europe for women (351 new cases
150 II, 5. 3. 5 | were reported in Eastern Europe for men (287 deaths per
151 II, 5. 3. 5 | 4a) and again in Northern Europe for women (155 deaths per
152 II, 5. 3. 5 | the exception of Eastern Europe and is decreasing or constant
153 II, 5. 3. 5 | Cancer (ICD-9 151)~In 2006 Europe saw, 160,000 new cases and
154 II, 5. 3. 5 | male incidence in Eastern Europe). Moreover, Eastern Europe
155 II, 5. 3. 5 | Europe). Moreover, Eastern Europe maintains higher levels (
156 II, 5. 3. 5 | for colorectal cancer in Europe (Ferlay et al, 2007). Figures
157 II, 5. 3. 5 | similar GDP. In 2006 Western Europe had maximum levels of incidence
158 II, 5. 3. 5 | mortality rates than the rest of Europe both for men (over 40 deaths
159 II, 5. 3. 5 | rapidly in Western and Eastern Europe mainly for men (Figure 5.
160 II, 5. 3. 5 | in Western and Northern Europe, while they are increasing
161 II, 5. 3. 5 | in Eastern and Southern Europe.~ ~Figure 5.3.9a. Colorectal
162 II, 5. 3. 5 | ICD-9 162)~In 2006, in Europe there were 386,000 new cases
163 II, 5. 3. 5 | cases per 100,000). Eastern Europe had maximum levels of incidence (
164 II, 5. 3. 5 | 100,000). While Northern Europe had the maximum incidence (
165 II, 5. 3. 5 | deaths in 2006 for the entire Europe (Ferlay et al, 2007). The
166 II, 5. 3. 5 | affluent world areas as for Europe could also depend by the
167 II, 5. 3. 5 | are decreasing in Northern Europe, Western Europe and Southern
168 II, 5. 3. 5 | Northern Europe, Western Europe and Southern Europe, whilst
169 II, 5. 3. 5 | Western Europe and Southern Europe, whilst they are constant
170 II, 5. 3. 5 | are constant in Eastern Europe.~ ~Figure 5.3.17. Female
171 II, 5. 3. 5 | deaths in 2002 for the entire Europe (Parkin et al, 2005). The
172 II, 5. 3. 5 | Western, Southern and Northern Europe (Figure 5.3.22 and Figure
173 II, 5. 3. 5 | estimated for prostate cancer in Europe (Ferlay et al, 2007). Comparison
174 II, 5. 3. 5 | Western, Northern and Southern Europe (Figure 5.3.26) reflects
175 II, 5. 3. 5 | are constant in Northern Europe, slightly decreasing in
176 II, 5. 3. 5 | in Western and Southern Europe, and increasing in Eastern
177 II, 5. 3. 5 | and increasing in Eastern Europe.~ ~Figure 5.3.25. Prostate
178 II, 5. 3. 6 | Western, Southern and Eastern Europe).~ ~
179 II, 5. 3. 6 | United Kingdom, Eastern Europe, Nordic countries, and West
180 II, 5. 3. 6 | countries, and West and South Europe) and Europe as a whole.
181 II, 5. 3. 6 | West and South Europe) and Europe as a whole. Europe-wide
182 II, 5. 3. 6 | 66%) occurred in Eastern Europe although still under the
183 II, 5. 3. 6 | were reported in Eastern Europe (Sant et al, 2003).~ ~Figure
184 II, 5. 3. 6 | of Northern and Western Europe with the best prognosis,
185 II, 5. 3. 6 | shown) indicate that in Europe there was a moderate improvement
186 II, 5. 3. 6 | 25 and 35% - in Eastern Europe (Estonia, Poland, Slovakia
187 II, 5. 3. 6 | shown) indicate that in Europe 5-year relative survival
188 II, 5. 3. 6 | shown) indicate that in Europe there was a modest tendency
189 II, 5. 3. 6 | survival for the entire Europe increased from 7.5% in men
190 II, 5. 3. 6 | most countries of Western Europe. In Finland, Sweden, France,
191 II, 5. 3. 6 | survival was seen in Eastern Europe (Estonia, Poland, Slovakia
192 II, 5. 3. 6 | more marked for Western Europe than in the Nordic countries,
193 II, 5. 3. 6 | Nordic countries and Western Europe has greatly reduced. There
194 II, 5. 3. 6 | except Denmark) and central Europe, intermediate in Southern
195 II, 5. 3. 6 | intermediate in Southern Europe, lower in the UK and Denmark,
196 II, 5. 3. 6 | Denmark, and worse in Eastern Europe. All-cancer survival correlated
197 II, 5. 3. 6 | although, patients in Eastern Europe had the highest improvement
198 II, 5. 3. 7 | occult blood or FOB test). In Europe breast, colorectal and cervical
199 II, 5. 3. 7 | cervical screening in Eastern Europe is one of the major cancer
200 II, 5. 3. 7 | trials are under way in Europe to establish whether screening
201 II, 5. 3. 7 | in cancer survival within Europe are way too large. The geographical
202 II, 5. 3. 7 | 2006) underlined that in Europe:~· There are wide differences
203 II, 5. 3. 7 | lack of homogeneity within Europe and a particular need for
204 II, 5. 3. 7 | its Health Strategies in Europe conference, stressed that
205 II, 5. 3. 7 | the Challenge of Cancer in Europe”, has been produced as a
206 II, 5. 3. 7 | cancer control activities in Europe.~ ~
207 II, 5. 3. 7 | collaboration~ ~Cancer research in Europe is of a high standard, but
208 II, 5. 3. 8 | Future developments~ ~In Europe the incidence rates for
209 II, 5. 3. 8 | cancer patients survival in Europe has strongly increased in
210 II, 5. 3. 8 | percentage of survival. In Europe we can estimate nearly 14
211 II, 5. 3. 8 | cancer control policy for Europe should address. We included
212 II, 5. 3. 8 | treatment facilities in Europe (especially in Eastern European
213 II, 5. 3. 8 | Systems expenditures in Europe while improving cancer services.~ ~
214 II, 5. 3. 9 | summary. Cancer survival in Europe at the end of the 20th century.
215 II, 5. 3. 9 | Medical Oncology Status in Europe Survey (MOSES). Phase II. htt 1 (
216 II, 5. 3. 9 | incidence and mortality in Europe in 2006. Ann Oncol 18(3):
217 II, 5. 3. 9 | Cancer Survival Trends in Europe: A EUROCARE Working Group
218 II, 5. 3. 9 | 2007) Health Strategies in Europe, 12 – 13 July 2007, Strategies
219 II, 5. 3. 9 | 2007) Health Strategies in Europe, 12 – 13 July 2007, Strategies
220 II, 5. 3. 9 | 2003): Cancer control in Europe: a proposed set of European
221 II, 5. 3. 9 | Recent cancer survival in Europe: a 2000–02 period analysis
222 II, 5. 3. 9 | cancer control programmes in Europe. htt f (document online,
223 II, 5. 4. 1 | have diabetes, followed by Europe with 53 million. India leads
224 II, 5. 4. 1 | s top.~The situation in Europe is among the most alarming.
225 II, 5. 4. 2 | WHO regional Offices for Europe and the European Region
226 II, 5. 4. 2 | best diabetes registers in Europe have adopted innovative
227 II, 5. 4. 2 | examples of this kind exist in Europe, showing a heterogeneous
228 II, 5. 4. 2 | collaborating registers in Europe (Carinci et al 2006).~In
229 II, 5. 4. 2 | QOC) information across Europe.~A landmark of QOC monitoring
230 II, 5. 4. 2 | landmark of QOC monitoring in Europe has been undoubtedly represented
231 II, 5. 4. 2 | systems currently existing in Europe, and beyond. Quality of
232 II, 5. 4. 2 | complications of this nature across Europe. Close monitoring of the
233 II, 5. 4. 2 | the highest priority in Europe with a total of 8 countries
234 II, 5. 4. 3 | North-South gradient in Europe, with a much higher incidence
235 II, 5. 4. 3 | attributable to diabetes across Europe.~ ~Secondary Indicators~ ~
236 II, 5. 4. 3 | currently affected by IGT in Europe is over 60 millions, and
237 II, 5. 4. 3 | three-fold variation across Europe of poor management, with
238 II, 5. 4. 4 | According to EUCID, obesity in Europe ranges between 12% (Netherlands)
239 II, 5. 4. 4 | is highly variable across Europe, flagging attention towards
240 II, 5. 4. 4 | that, on average, a town of Europe with 100 000 inhabitants
241 II, 5. 4. 4 | highlight that health systems in Europe are not optimally organized
242 II, 5. 4. 6 | for knowledge sharing in Europe. The initiative will probably
243 II, 5. 4. 6 | highest prevalence rates in Europe, and will rank among the
244 II, 5. 4. 6 | living with diabetes across Europe. Clinical guidelines are
245 II, 5. 4. 6 | Federation – European Region (IDF Europe) and the Federation of European
246 II, 5. 4. 6 | public health challenge in Europe and encouraging networking
247 II, 5. 4. 6 | of this research across Europe;~· Examining and strengthening
248 II, 5. 4. 8 | in the EU25 FEND /IDF - Europe 2006, available at: [http://
249 II, 5. 4. 8 | of childhood diabetes in Europe. Lancet 11;355 873-6~EUDIP
250 II, 5. 4. 8 | Diabetes. The Policy puzzle: is Europe making progress? FEND/IDF -
251 II, 5. 4. 8 | making progress? FEND/IDF - Europe 2008, [http://www.fend.org/
252 II, 5. 4. 8 | cost of Type II diabetes in Europe. Diabetologia, 2002; 45(
253 II, 5. 5.Int | and premature mortality in Europe with women twice as susceptible
254 II, 5. 5.Int | Mental health services in Europe have been identified as
255 II, 5. 5.Int | highly stigmatised across Europe. Depression affects 10-15%
256 II, 5. 5.Int(15)| Depression among older people in Europe: the EURODEP studies. World
257 II, 5. 5.Int | children and adolescents in Europe with active epilepsy is
258 II, 5. 5.Int(19)| dementia and major subtypes in Europe: A collaborative study of
259 II, 5. 5.Int | organizations (e.g. Mental Health Europe, EUFAMI, EnterMentalHealth,)
260 II, 5. 5.Int | continuous improvement throughout Europe in mental health, the quality
261 II, 5. 5. 1 | more common among women; in Europe, prevalence is 9% for adult
262 II, 5. 5. 1 | common (Lecrubier, 2007). In Europe, only one third of those
263 II, 5. 5. 1 | another. In general, in Europe hanging, shooting and self-poisoning
264 II, 5. 5. 1 | by country and gender in Europe are presented in Table 5.
265 II, 5. 5. 1 | 000 people) by gender in Europe~ ~The stability of inter-country
266 II, 5. 5. 1 | accidents (per 100 000) in Europe.~ ~The changes in age-adjusted
267 II, 5. 5. 1 | age group and gender in Europe~ ~As regards to the gender,
268 II, 5. 5. 1 | serious health problems in Europe in terms of severity of
269 II, 5. 5. 1 | Stress Related Disorders in Europe (2001-3) targeted people
270 II, 5. 5. 1 | Prevalence of mental disorders in Europe: results from the European
271 II, 5. 5. 1 | mental health services in Europe: results from the European
272 II, 5. 5. 1 | factors for suicidality in Europe: results from the ESEMED
273 II, 5. 5. 1 | Suicidal behaviour in Europe - Results from the WHO/EURO
274 II, 5. 5. 1 | Cost of depression in Europe. J Mental Health Policy
275 II, 5. 5. 1 | 2008). Suicide methods in Europe: a gender-specific analysis
276 II, 5. 5. 2 | prevalence of dementia in Europe and in the world, and our
277 II, 5. 5. 2 | prevalence rates for Western Europe (Region A) and Eastern Europe (
278 II, 5. 5. 2 | Europe (Region A) and Eastern Europe (Regions B and C)23. ~ ~
279 II, 5. 5. 2 | over. Ferri et al separated Europe into Western Europe and
280 II, 5. 5. 2 | separated Europe into Western Europe and Eastern Europe, with
281 II, 5. 5. 2 | Western Europe and Eastern Europe, with a further division
282 II, 5. 5. 2 | further division in Eastern Europe between countries with a
283 II, 5. 5. 2 | in the overall total for Europe.~ ~ ~
284 II, 5. 5. 2 | from EUROSTAT, Alzheimer Europe calculated the estimated
285 II, 5. 5. 2 | dementia in each country within Europe and in Iceland, Norway,
286 II, 5. 5. 2 | Switzerland and Turkey (Alzheimer Europe, 2006). The results are
287 II, 5. 5. 2 | future trends~ ~Alzheimer Europe also looked at the development
288 II, 5. 5. 2 | 1960 to 2005 (Alzheimer Europe, 2006a). Figure 5.5.2.1.
289 II, 5. 5. 2 | For this reason, Alzheimer Europe decided to address this
290 II, 5. 5. 2 | project partners of Alzheimer Europe are currently carrying out
291 II, 5. 5. 2 | prevalence studies in whole Europe, including the new Member
292 II, 5. 5. 2 | when available) (Alzheimer Europe, 2007).~ ~
293 II, 5. 5. 2 | the framework of Alzheimer Europe’s EuroCoDe project, a working
294 II, 5. 5. 2 | the end of 2008 (Alzheimer Europe, 2007).~ ~
295 II, 5. 5. 2 | with dementia. Alzheimer Europe is currently carrying out
296 II, 5. 5. 2 | December 2008.~ ~The Council of Europe has nominated a NGO Health
297 II, 5. 5. 2 | relatives.~ ~In 2007, Alzheimer Europe received funding from DG
298 II, 5. 5. 2 | Dementia – EuroCoDe” (Alzheimer Europe, 2007). This led to the
299 II, 5. 5. 2 | is different. Alzheimer Europe and its member organisations
300 II, 5. 5. 2 | respite care).~ ~Lastly, as Europe’s population continues to
301 II, 5. 5. 2 | Alzheimer’s disease (Alzheimer Europe, 2007a). The declaration
302 II, 5. 5. 2 | priorities endorsed by Alzheimer Europe member organisations and
303 II, 5. 5. 2 | health inequalities across Europe and improving the level
304 II, 5. 5. 2 | to supporting Alzheimer Europe and its members in making
305 II, 5. 5. 2 | public health priority in Europe (European Parliament, 1996).~ ~
306 II, 5. 5. 2 | References~ ~Alzheimer Europe (2006): Dementia in Europe
307 II, 5. 5. 2 | Europe (2006): Dementia in Europe Yearbook. Alzheimer Europe~ ~
308 II, 5. 5. 2 | Europe Yearbook. Alzheimer Europe~ ~Alzheimer Europe (2007):
309 II, 5. 5. 2 | Alzheimer Europe~ ~Alzheimer Europe (2007): EuroCoDe, WP4 survey
310 II, 5. 5. 2 | finalised in 2008)~ ~Alzheimer Europe (2007a): Paris Declaration
311 II, 5. 5. 2 | Available at:~htt ~ ~Alzheimer Europe (2006a): Who cares? The
312 II, 5. 5. 2 | state of dementia care in Europe. Alzheimer Europe~ ~Alzheimer
313 II, 5. 5. 2 | care in Europe. Alzheimer Europe~ ~Alzheimer Scotland (2006):
314 II, 5. 5. 2 | definition and concept, Alzheimer Europe. Available at: htt B (article
315 II, 5. 5. 3 | WHO Regional Office for Europe and was realised for the
316 II, 5. 5. 3 | of Obesity in Children in Europe; Volume 2: Available Health
317 II, 5. 5. 3 | of Obesity in Children in Europe” written by Alexander et
318 II, 5. 5. 3 | of data availability in Europe~ ~ ~Country / Measure~Availability
319 II, 5. 5. 3 | of Obesity in Children in Europe; Volume 2: Available Health
320 II, 5. 5. 3 | of Obesity in Children in Europe)~ ~A third European study
321 II, 5. 5. 3 | titled Healthy Lifestyle in Europe by Nutrition in Adolescence (
322 II, 5. 5. 3 | habits of adolescents in Europe, and tries to get a better
323 II, 5. 5. 3 | young females in Western Europe and the United States was
324 II, 5. 5. 3 | WHO Regional Office for Europe implemented a strategy for
325 II, 5. 5. 3 | WHO Regional Office for Europe points out main factors
326 II, 5. 5. 3 | measure disordered eating in Europe and should, moreover, implement
327 II, 5. 5. 3 | of Obesity in Children in Europe; Volume 1: The Public Health
328 II, 5. 5. 3 | of Obesity in Children in Europe; Volume 2: Available Health
329 II, 5. 5. 3 | of Obesity in Children in Europe, in press~Anorexia Nervosa
330 II, 5. 5. 3 | Showcases Healthy lifestyle in Europe by nutrition in 13-16 years
331 II, 5. 5. 3 | years adolescents across Europe. Available at: htt l (article
332 II, 5. 5. 3 | Project—Healthy Lifestyle in Europe by Nutrition in Adolescence.
333 II, 5. 5. 3 | WHO Regional Office for Europe.~ ~
334 II, 5. 5. 3 | HELENA~Healthy Lifestyle in Europe by Nutrition in Adolescence~
335 II, 5. 5. 3 | WHO Regional Office for Europe~World Health Organization
336 II, 5. 5. 3 | Organization Regional Office for Europe~ ~ ~
337 II, 5. 5. 3 | publication and coverage across Europe is however patchy. Another
338 II, 5. 5. 3 | WHO Regional Office for Europe. Other data and information
339 II, 5. 5. 3 | contributors to DALYs in Europe are neuropsychiatric disorders (
340 II, 5. 5. 3 | of studies from Western Europe note 17.8%, while estimates
341 II, 5. 5. 3 | estimates in the WHO Report for Europe 2001 were much higher, namely
342 II, 5. 5. 3 | Research and Evaluation Europe) instrument, a rating scale
343 II, 5. 5. 3 | Mental health service in Europe~Not only the lack of resources
344 II, 5. 5. 3 | reflected in the fact that Europe has a lower proportion of
345 II, 5. 5. 3 | costs of brain disorders in Europe by an analysis of studies
346 II, 5. 5. 3 | system. www Mental Health in Europe 2001 - Country reports from
347 II, 5. 5. 3 | disorders of the brain in Europe. Eur J Neurol 12 Suppl 1:
348 II, 5. 5. 3 | of psychotic disorders in Europe. Eur J Neurol 12 Suppl 1:
349 II, 5. 5. 3 | recognition and intervention in Europe. World Psychiatry 4(3):161-
350 II, 5. 5. 3 | Policy and Practice across Europe – The future direction of
351 II, 5. 5. 3 | 2001a) - WHO Regional Office Europe: Mental Health in Europe.
352 II, 5. 5. 3 | Europe: Mental Health in Europe. Country Reports from the
353 II, 5. 5. 3 | 2005d) -WHO Regional Office Europe: Helsinki Mental Health
354 II, 5. 5. 3 | Mental Health Declaration for Europe. Facing the Challenges,
355 II, 5. 5. 3 | contributed to this. Equally, in Europe, the social and economic
356 II, 5. 5. 3 | data on morbidity in ASD in Europe. Controversy exists in the
357 II, 5. 5. 3 | ASD prevalence study in Europe. This is a relevant action
358 II, 5. 5. 3 | case definition of ASD in Europe is still not fully harmonized,
359 II, 5. 5. 3 | ASD information system in Europe.~Tools have been developed
360 II, 5. 5. 3 | families affected by ASD in Europe. The initiative by the Welsh
361 II, 5. 5. 3 | With few exceptions, in Europe the information existing
362 II, 5. 5. 3 | consequences of the disease in Europe and in the rest of the world.~
363 II, 5. 5. 3 | description and analysis~ ~In Europe, the incidence, prevalence
364 II, 5. 5. 3 | expects that, at least in Europe, genetic susceptibility
365 II, 5. 5. 3 | incidence studies carried out in Europe have been identified, mostly
366 II, 5. 5. 3 | Incidence of epilepsy in Europe~ ~Table 5.5.3.4.2. Incidence (
367 II, 5. 5. 3 | 100,000) of epilepsy in Europe, by age~ ~With one exception (
368 II, 5. 5. 3 | and unprovoked seizures in Europe has been reported to be
369 II, 5. 5. 3 | temporal trends of epilepsy in Europe. No overall trends have
370 II, 5. 5. 3 | in Northern and Southern Europe. This observation can be
371 II, 5. 5. 3 | of epileptic syndromes in Europe. In Iceland (Olafsson et
372 II, 5. 5. 3 | prevalence of epilepsy in Europe (Forsgren et al, 2005).
373 II, 5. 5. 3 | Prevalence of active epilepsy in Europe~Modified from Forsgren,
374 II, 5. 5. 3 | the SMR for epilepsy in Europe was found to range from
375 II, 5. 5. 3 | Observed~Expected~ ~ ~Europe~Insurance policies~Prevalent
376 II, 5. 5. 3 | in several studies from Europe. In contrast, data regarding
377 II, 5. 5. 3 | particularly in Central and Eastern Europe, where unemployment rates
378 II, 5. 5. 3 | greater than those of Western Europe (Anonymous, 2003). These
379 II, 5. 5. 3 | epilepsy and driving in Europe~ ~__ __~Country Group Seizure
380 II, 5. 5. 3 | achieve harmonization across Europe. On April 27 2005, the SEWGED
381 II, 5. 5. 3 | epidemiology of epilepsy in Europe – a systematic review. Eur
382 II, 5. 5. 3 | mortality was reviewed for Europe with regards to “European
383 II, 5. 5. 3 | hereafter referred to as “Europe”. Articles published in
384 II, 5. 5. 3 | MS case registers in ”Europe”~Population-based registries
385 II, 5. 5. 3 | in time and space across Europe are summarised here. Tables
386 II, 5. 5. 3 | of Multiple Sclerosis in Europe~ ~ ~Systematic surveys in
387 II, 5. 5. 3 | In brief, prevalence in Europe ranges from approx. 20 to
388 II, 5. 5. 3 | annual mean MS incidence in Europe is estimated to be 4 per
389 II, 5. 5. 3 | The distribution of MS in Europe by disease course~ ~The
390 II, 5. 5. 3 | The distribution of MS in Europe by severity~The prevalence-based
391 II, 5. 5. 3 | rates and survival time in Europe~Data on MS mortality must
392 II, 5. 5. 3 | elevated risk for death in Europe, with mortality ranging
393 II, 5. 5. 3 | overview of mortality rates in Europe is reported in Table 7 Decreasing
394 II, 5. 5. 3 | The epidemiology of MS in Europe: methodological issues~Despite
395 II, 5. 5. 3 | geographical pattern of MS in Europe is a hard task due to: (
396 II, 5. 5. 3 | prevalence rates across Europe has been observed. Although
397 II, 5. 5. 3 | current epidemiology of MS in Europe was categorisation, and
398 II, 5. 5. 3 | socio-economic burden of MS in Europe~ ~The disability adjusted
399 II, 5. 5. 3 | The total DALY for MS in Europe is 307 000 years and varies
400 II, 5. 5. 3 | The cost per MS case in Europe ranges from €10 000 to €
401 II, 5. 5. 3 | Distribution of total cost of MS in Europe (year 2005) by resource
402 II, 5. 5. 3 | management of MS are available in Europe, i.e., beta-interferons
403 II, 5. 5. 3 | situation of people with MS in Europe, but only reports from a
404 II, 5. 5. 3 | experiences of people with MS in Europe. It did so with regard to
405 II, 5. 5. 3 | with Multiple Sclerosis in Europe by the European Multiple
406 II, 5. 5. 3 | Sclerosis Rehabilitation in Europe; their target is to contribute
407 II, 5. 5. 3 | severely affected by MS in Europe to have access to palliative
408 II, 5. 5. 3 | societies from the wider part of Europe they constitute the European
409 II, 5. 5. 3 | of multiple sclerosis in Europe; good practice review of
410 II, 5. 5. 3 | with Multiple Sclerosis in Europe~Baumhackl U, Eibl G, Ganzinger
411 II, 5. 5. 3 | Multiple Sclerosis in Europe: An Epidemiological Update.
412 II, 5. 5. 3 | Multiple Sclerosis in Europe: An Epidemiological Update.
413 II, 5. 5. 3 | Multiple Sclerosis in Europe: An Epidemiological update.
414 II, 5. 5. 3 | Multiple Sclerosis in Europe: An Epidemiological Update.
415 II, 5. 5. 3 | Multiple Sclerosis in Europe: An Epidemiological Update.
416 II, 5. 5. 3 | study of four centres in Europe. Neuroepidemiology 5:71-
417 II, 5. 5. 3 | of multiple sclerosis in Europe. Eur J Neurol 13: 700–722.~
418 II, 5. 5. 3 | Estimation of the cost of MS in Europe: Extrapolations from a multinational
419 II, 5. 5. 3 | 10.7 billion per year in Europe (Andlin-Sobocki et al, 2005).~
420 II, 5. 5. 3 | of Parkinson’s disease in Europe~ ~Figure 5.5.3.6.1. Estimated
421 II, 5. 5. 3 | of Parkinson’s disease in Europe.~ ~Crude incidence estimates
422 II, 5. 5. 3 | of Parkinson’s disease in Europe.~ ~Estimates of crude prevalence
423 II, 5. 5. 3 | distribution of PD severity in Europe seems quite similar in most
424 II, 5. 5. 3 | stage~ ~Crude incidences in Europe range from 5 per 100,000
425 II, 5. 5. 3 | differed significantly across Europe, ranging from €2,500 (Estonia) – €
426 II, 5. 5. 3 | cost-of-illness studies in Europe. Furthermore, standardized
427 II, 5. 5. 3 | awareness of brain disorders in Europe (htt ). Among others, it
428 II, 5. 5. 3 | evaluation of brain disorders in Europe (Andlin-Sobocki et al, 2005).
429 II, 5. 5. 3 | was estimated for Western Europe's 5 most and the world's
430 II, 5. 5. 3 | disorders of the brain in Europe. Eur J Neurol 12 Suppl 1:
431 II, 5. 5. 3 | and Parkinson’s disease in Europe: the EUROPARKINSON Collaborative
432 II, 5. 5. 3 | of Parkinson’s disease in Europe. Eur J Neurol 12 Suppl 1:
433 II, 5. 5. 3 | of Parkinson’s disease in Europe. Eur Neuropsychopharmacol
434 II, 5. 6. 1 | and governments throughout Europe, through support of the
435 II, 5. 6. 1 | non-communicable diseases in Europe in the WHO European Strategy (
436 II, 5. 6. 3 | derived from studies in Europe and North America (Symmons,
437 II, 5. 6. 3 | arthritis.~ ~Prevalence~ ~In Europe, just over one-fifth (22%)
438 II, 5. 6. 3 | top 10 causes of DALY in Europe (WHO European Strategy for
439 II, 5. 6. 3 | Prevalence of knee OA in Europe~ ~Figure 5.6.4a. Prevalence
440 II, 5. 6. 3 | individual studies across Europe.~ ~Prevalence~ ~For both
441 II, 5. 6. 3 | in the next 10 years in Europe due to the ageing populations.
442 II, 5. 6. 3 | been reported from Northern Europe (EULAR Online Course, 2008).~ ~
443 II, 5. 6. 3 | elderly women than men). In Europe it has been estimated that
444 II, 5. 6. 3 | and women aged over 50 in Europe. The rates vary between
445 II, 5. 6. 3 | three-fold variation across Europe and up to two-fold variation
446 II, 5. 6. 3 | is increasing throughout Europe, and the number of hip fractures
447 II, 5. 6. 4 | ageing of the population in Europe will result in the number
448 II, 5. 6. 5 | opinion of experts from across Europe in the areas of rheumatology,
449 II, 5. 6. 6 | of vertebral fractures in Europe: results from the European
450 II, 5. 6. 6 | Management of Osteoporosis in Europe. Osteoporos Int 16(3):229-
451 II, 5. 6. 6 | Available at URL : ht ~ ~WHO Europe (2006): Gaining Health.
452 II, 5. 6. 6 | 56th Session of the WHO Europe Regional Committee for Europe,
453 II, 5. 6. 6 | Europe Regional Committee for Europe, Copenhagen, 11-14 September
454 II, 5. 6. 6 | Musculoskeletal pain in Europe: its impact and a comparison
455 II, 5. 7. 1 | magnitude in those countries. In Europe several surveys have now
456 II, 5. 7. 1 | the renal registries in Europe. Although rare, CKD and
457 II, 5. 7. 1 | of healthcare funding in Europe is spent on treating dialysis
458 II, 5. 7. 2 | regional renal registries in Europe and countries bordering
459 II, 5. 7. 3 | data has been published in Europe. In the Atherosclerosis
460 II, 5. 7. 3 | Coresh et al,2005).~ ~In Europe similar data are available
461 II, 5. 7. 3 | are similar to those in Europe, incidence rates in US whites (
462 II, 5. 7. 3 | 5-3 times as high as in Europe. This is partly due to a
463 II, 5. 7. 3 | of data on CKD. Data in Europe have been gathered both
464 II, 5. 7. 3 | children (<20 years) in Europe is about 60 cases pmarp (
465 II, 5. 7. 3 | in European countries.~In Europe over the period 1992-2005 (
466 II, 5. 7. 3 | Mortality on RRT is lower in Europe compared to the US (Sixth
467 II, 5. 7. 3 | Registry, 2005). Also within Europe there are considerable differences
468 II, 5. 7. 3 | of data on CKD. Data in Europe have been gathered both
469 II, 5. 7. 6 | other chronic diseases.~ ~In Europe there is still no document
470 II, 5. 7. 6 | is expected to grow.~ ~In Europe the availability of cadaver
471 II, 5. 7. 7 | end-stage renal disease in Europe, 1990-1999. Nephrol Dial
472 II, 5. 7. 7 | end-stage renal disease in Europe, Canada and the Asia-Pacific
473 II, 5. 8. 1 | people die every year in Europe because of COPD. It represents
474 II, 5. 8. 2 | journals~- Lung Health in Europe Facts & Figures, from European
475 II, 5. 8. 2 | Organization,~ Regional Office for Europe~ ~Although COPD and asthma
476 II, 5. 8. 3 | annual cost for COPD in Europe (excluding mortality and
477 II, 5. 8. 3 | in Central and Eastern Europe lost work days due to COPD
478 II, 5. 8. 7 | on respiratory health in Europe”. Loddenkemper R, Gibson
479 II, 5. 8. 7 | respiratory research in Europe: FP7. Eur Respir J 2007;
480 II, 5. 9.Acr | Asthma Insights & Reality in Europe~AR~Atopic Rhinitis~ARIA~
481 II, 5. 9. FB | major health concern in Europe, with over 80 million people
482 II, 5. 9. FB | homogeneous lifestyles throughout Europe, allergy prevalence among
483 II, 5. 9. FB | 80 million people across Europe are estimated to suffer
484 II, 5. 9. FB | populations living in Western Europe compared to those living
485 II, 5. 9. FB | of allergic diseases in Europe seen particularly in the
486 II, 5. 9. FB | allergic diseases across Europe could be partially explained
487 II, 5. 9. FB | exposure to microbes seen in Europe in the last decades, due
488 II, 5. 9. FB | begin an early treatment. In Europe,,allergic patients are currently
489 II, 5. 9. 2 | Program;~- Lung Health in Europe Facts & Figures, from European
490 II, 5. 9. 3 | patients died. (Lung Health in Europe, 2003 ERJ)~ ~According to
491 II, 5. 9. 3 | public health problem in Europe, The UCB Institute of Allergy,
492 II, 5. 9. 3 | costs.~ ~At the moment, in Europe allergic patients are underestimated,
493 II, 5. 9. 3 | billion) (Lung Health in Europe Facts & Figures, 2003 ERJ).
494 II, 5. 9. 3 | burden of asthma care in Europe is consistent and the direct
495 II, 5. 9. 3 | billion) (Lung Health in Europe, 2003).~ ~In a review of
496 II, 5. 9. 4 | judaica is higher in Southern Europe than in Northern Europe
497 II, 5. 9. 4 | Europe than in Northern Europe and sensitization to the
498 II, 5. 9. 4 | birch is higher in Northern Europe than in Southern Europe.
499 II, 5. 9. 4 | Europe than in Southern Europe. These patterns could be
500 II, 5. 9. 4 | respiratory allergies in Europe. The partners collected
